-+ 0.00%
-+ 0.00%
-+ 0.00%

OCULIS ANNOUNCES U.S. FDA BREAKTHROUGH THERAPY DESIGNATION GRANTED TO PRIVOSEGTOR FOR TREATMENT OF OPTIC NEURITIS

路透·01/06/2026 09:00:00

登录查看新闻详情